Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H

被引:52
|
作者
Logrip, Marian L. [1 ,2 ]
Janak, Patricia H. [1 ,2 ,3 ]
Ron, Dorit [1 ,2 ,3 ]
机构
[1] Ernest Gallo Res Ctr, Emeryville, CA 94608 USA
[2] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
Dynorphin; Kappa opioid receptor; Reward; Ethanol; CPP; CONDITIONED PLACE PREFERENCE; STRIATAL DOPAMINE LEVELS; MESSENGER-RNA CONTENT; BRAIN-REGIONS; COCAINE; ACTIVATION; DYNORPHIN; STRESS; SENSITIZATION; INCREASES;
D O I
10.1016/j.alcohol.2009.05.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcoholism is a pervasive social problem, and thus understanding factors that regulate alcohol (ethanol) reward is important for designing effective therapies. One putative regulatory system includes the kappa opioid receptor (KOR) and its endogenous ligand, dynorphin. Previously, we demonstrated that acute ethanol increased preprodynorphin expression via brain-derived neurotrophic factor (BDNF) in striatal neurons, and that blockade of the KOR attenuated decreases in ethanol intake observed following increased expression of BDNF. As high doses of KOR agonists can generate an aversive state, we hypothesized that endogenous dynorphin may regulate ethanol intake by interfering with the rewarding properties of ethanol. We found that low, nonaversive doses of the KOR agonist U50,488H blocked the rewarding properties of ethanol during conditioning, thus impairing the acquisition of conditioned place preference. Importantly, we demonstrate that U50,488H also inhibited the conditioned increase in locomotor activation normally observed in the ethanol-paired chamber on test day. Taken together, these data indicate that the KOR/dynorphin system may acutely regulate ethanol intake via inhibition of the rewarding properties of ethanol. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 50 条
  • [1] BLOCKADE OF U50,488H ANALGESIA BY ANTISENSE OLIGODEOXYNUCLEOTIDES TO A KAPPA-OPIOID RECEPTOR
    CHIEN, CC
    BROWN, G
    PAN, YX
    PASTERNAK, GW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (03) : R7 - R8
  • [2] Modulation of DPK cell function by the kappa opioid agonist U50,488H
    Guan, LM
    Eisenstein, TK
    Adler, MW
    Rogers, TJ
    DRUGS OF ABUSE, IMMUNOMODULATION, AND AIDS, 1998, 437 : 125 - 136
  • [3] The selective κ-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat
    Lindholm, S
    Werme, M
    Brené, S
    Franck, J
    BEHAVIOURAL BRAIN RESEARCH, 2001, 120 (02) : 137 - 146
  • [4] CARDIOVASCULAR ACTIONS OF THE KAPPA-AGONIST, U-50,488H, IN THE ABSENCE AND PRESENCE OF OPIOID RECEPTOR BLOCKADE
    PUGSLEY, MK
    PENZ, WP
    WALKER, MJA
    WONG, TM
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (03) : 521 - 526
  • [5] The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
    Peng Huang
    Taylor A. Gentile
    John W. Muschamp
    Lee-Yuan Liu-Chen
    BMC Research Notes, 13
  • [6] The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
    Huang, Peng
    Gentile, Taylor A.
    Muschamp, John W.
    Liu-Chen, Lee-Yuan
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [7] THE KAPPA-OPIOID RECEPTOR AGONIST, U50,488H, EXERTS ANTIDYSTONIC ACTIVITY IN A MUTANT HAMSTER MODEL OF GENERALIZED DYSTONIA
    RICHTER, A
    LOSCHER, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (02) : 289 - 294
  • [8] Diet and lighting conditions modify the effects of the kappa opioid agonist U50,488H on feeding behavior in rats
    Kanarek, RB
    D'Anci, KE
    NUTRITIONAL NEUROSCIENCE, 2000, 3 (04) : 231 - 243
  • [9] THE KAPPA-OPIOID RECEPTOR AGONIST U50,488H INDUCES ACUTE PHYSICAL-DEPENDENCE IN GUINEA-PIGS
    BRENT, PJ
    CHAHL, LA
    CANTARELLA, PA
    KAVANAGH, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) : 149 - 156
  • [10] Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H
    Guan, LM
    Eisenstein, TK
    Adler, MW
    Rogers, TJ
    JOURNAL OF NEUROIMMUNOLOGY, 1997, 75 (1-2) : 163 - 168